Neuro & Signalling Research

Semax 10mg

£19.00

Semax 10mg · 10mg nominal

Single-material vial listing; lyophilised research product as catalogued. Not a ready-to-use solution, pen or refill. ACTH-derived Semax peptide studied in rat-brain neurotrophin transcription. For in-vitro laboratory research only; not for human or veterinary use.

Request batch documentation

Description

Semax 10mg from Core Research is a research-only catalogue item. Nominal 10mg vial of lyophilised Semax for laboratory research. The useful evidence concerns rat-brain neurotrophin transcription and cerebral-ischaemia models, not a proven cognitive effect of the supplied product. For in-vitro laboratory research only; not for human or veterinary use.

What exactly is supplied?

Nominal 10mg vial of lyophilised Semax for laboratory research. The useful evidence concerns rat-brain neurotrophin transcription and cerebral-ischaemia models, not a proven cognitive effect of the supplied product. The amount on the product name is a catalogue declaration, not a measurement of mass, chemical purity or content for an individual lot. Check the product and the applicable documentation if a specification is essential to your experiment.

Attribute What the product page establishes
Exact catalogue listing Semax 10mg
Labelled quantity 10mg nominal per listed item
Presentation Lyophilised vial
Research entity Semax (ACTH(4–7)–PGP)
Declared use In-vitro laboratory research only; not human or veterinary use
Lot evidence Request the report applicable to the lot and exact format proposed for dispatch

The supplied label and any quality record should identify the lot. If you need the exact chemical form, sequence, terminal groups, counter-ion, mass basis, analytical identity or content, ask for a record tied to this product. Literature references and reference-database formulae are not supplier assay data.

How does this compare with the other formats?

These are separate catalogue products. A name shared across vial, refill and pen listings does not establish identical packaging, fill, solvent, compatibility, concentration or shelf life. A related molecule is not a substitutable chemical merely because it appears in the same research category.

Catalogue item Why the distinction matters
Semax 10mg — this listing Single-material vial listing; lyophilised research product as catalogued. Not a ready-to-use solution, pen or refill.
Semax Refill 10mg Separate refill-cartridge format
Selank 10mg Different peptide lineage and evidence base

For the same named peptide, the vial and refill have related entity-level literature but different practical evidence needs. Where a study depends on solvent, contact materials or dispensing characteristics, the format change is an experimental variable, not a cosmetic catalogue difference.

Why is Semax (ACTH(4–7)–PGP) researched?

Semax is generally described in the experimental literature as a seven-residue peptide combining an ACTH-derived fragment with a C-terminal proline–glycine–proline extension. Literature descriptions using ACTH(4–7)PGP and ACTH(4–10)-related notation must not substitute for verifying the exact synthetic sequence and terminal form supplied.

Scope of the studies selected below: Neurotrophin gene expression in rat brain, permanent and transient cerebral-ischaemia experiments, and the difference between transcriptional responses and measured clinical outcomes.

A neuropeptide design derived from ACTH

Semax is a synthetic heptapeptide designed from a short N-terminal fragment of the adrenocorticotropic-hormone sequence and a proline–glycine–proline segment. The PGP extension is relevant to studying peptide stability and the biological effects of fragments. A source paper that tests PGP alone is therefore not direct evidence for every response to the full Semax sequence. 1, 2

Its name appears in experimental neurobiology, but its research identity should be treated like any other synthetic peptide: verify the sequence, terminal modifications, counter-ion and observed analytical ions for the specific material. A catalogue label by itself does not establish these properties.

Brain regions can give opposite transcriptional signals

Agapova and colleagues investigated the expression of Bdnf and Ngf in brain regions of rats after experimental Semax exposure. They reported region-specific responses: hippocampal and some other brain measurements increased, while Ngf expression decreased in the frontal cortex under the reported conditions. This is a reason to report the tissue, gene, method and observation window rather than writing that Semax simply “raises BDNF and NGF”. 1

The measured endpoint was messenger RNA, determined using a gene-expression assay. More transcript does not guarantee proportional protein production, receptor engagement, synaptic adaptation or an improvement in behaviour. Effects may differ when tissue is stressed rather than healthy. 1

Comparing intact brain and an ischaemia model

A later rat permanent middle-cerebral-artery-occlusion study compared Semax with the shorter PGP fragment across several times following injury. Both were associated with changes in transcription of neurotrophins or their receptors, but their gene and timing patterns only partly overlapped. Some responses appeared earlier, others later. The important contribution is how the injury model changes the biological question—not a suggestion that two related peptides are functionally identical. 2

An animal cortex transcript profile does not demonstrate clinical protection of human brain tissue. A laboratory would need prespecified protein, cell-survival and functional readouts to make stronger statements about a proposed causal pathway. 2

Inflammatory transcripts after experimental injury

Dergunova and colleagues used qRT-PCR in a rat ischaemia–reperfusion model to investigate genes encoding inflammatory mediators. They reported that Semax exposure reduced some of the induced mRNA responses, including several interleukin- and chemokine-associated transcripts. The paper also explained why low-abundance transcripts required a more targeted measurement than its earlier broad RNA-sequencing work. 3

The difference between qRT-PCR confirmation and an inferred cytokine-function change matters. An mRNA reduction under a controlled rat injury paradigm is not a measure of human safety, cognition, or a therapeutic outcome for the vial supplied here. 3

Evidence limits

These papers are selected non-clinical studies and do not establish that the current supplier vial produces a human cognitive or neurological effect. The discussion is intended for experimental design and source interpretation, not personal treatment or administration.

What analytical evidence matters for this exact item?

A relevant certificate or analytical report should identify the tested material, reported lot, form and method. Separate identity (what was tested), purity (how the major signal relates to impurities under one method), content (how much material was measured) and the packaging/fill specification. A cited paper investigates the research entity; it does not certify the vial or cartridge supplied here.

Use Batch Documentation to enquire before purchase, specifying “Semax 10mg” and your required tests. No existing order or container lot is needed to make a pre-purchase enquiry under Core Research’s published documentation route. After delivery, match the returned report to the supplied lot rather than assuming a certificate for another item applies.

The guide to reading a peptide CoA explains how to identify the tested sample; the HPLC guide distinguishes chromatographic peak area from measured content, and the mass-spectrometry guide explains how observed ions and expected identity differ. An absent lot-specific result is treated as unknown, never as a default purity or sterility claim.

Peptide sequence and study comparability

Confirm the synthetic sequence and terminal chemistry, and distinguish it from the short fragments or parent peptides described in some papers. Research that used a metabolite, precursor or related signalling molecule should not be treated as direct product-lot evidence.

Vial format and nominal amount

This product is the standalone vial listing. A nominal dry-material amount is not an aqueous concentration, a number of samples or a verified peptide-content assay. Any solution properties depend on the actual compound form, solvent, container, method and controls, which this page does not specify.

Storage, dispatch and laboratory receiving

Follow the conditions documented on the supplied label or applicable product/lot specification. Fixed refrigerated/frozen shelf lives, dry-product expiry, prepared-solution lifetime and transport-temperature promises are not inserted without appropriate evidence. An unopened material and a prepared solution have different possible stability concerns.

Proteolysis, surface adsorption, oxidation or aggregation may affect peptide experiments depending on the chemistry and preparation. The relevant tests and any storage conditions belong in the actual specification and laboratory method, not an unsourced universal rule.

At receipt, record the name, quantity, batch/lot identifier, packaging condition and closure. Compare them against the purchase record and any available certificate. The research-product receiving checklist provides the workflow; for delayed or unexpectedly warm deliveries use the arrival-condition guide and retain photographs/tracking where relevant.

Core Research publishes UK dispatch from Birmingham and plain, unmarked outer packaging. Tracking is supplied where provided by the chosen service. The actual delivery charge and expected timing depend on destination, order and checkout options; no universal next-day or temperature-controlled service is promised by this product draft.

Ordering and support

Select the desired quantity using the native WooCommerce purchase panel; current price, availability and the available checkout methods are determined by the live site, not by this static description. For supplier, material or lot questions, contact Core Research before placing an order.

Request batch documentation · Ask about this product · Institutional procurement · Shipping & Delivery

The supplied research material is not intended for clinical treatment, disease prevention, human or veterinary administration, food, cosmetic self-use or any unsupervised personal procedure.

Frequently asked ordering and laboratory questions

What is included in this product?

Single-material vial listing; lyophilised research product as catalogued. Not a ready-to-use solution, pen or refill. The catalogue amount is 10mg nominal. Confirm any accessory, packaging or filled-state requirement before buying.

Can I request batch documentation before ordering?

Yes. The published documentation route accepts pre-purchase enquiries naming the product and presentation. Ask for the actual tests and lot applicability needed by your laboratory; a reply or historical certificate should not be mistaken for a guaranteed current-lot assay.

Does the labelled amount determine the concentration or experimental sample count?

No. A labelled mass is not a liquid volume or measured solution concentration. Experimental consumption depends on method, assay design and validated material-content basis. This page does not provide a preparation or use protocol.

Is this a medicinal or ready-to-administer product?

No. This listing is restricted to in-vitro laboratory research and does not provide a therapeutic, cosmetic, veterinary or personal-use indication.

What research finding is most important to interpret carefully?

Rat-brain neurotrophin messenger-RNA changes differ by region and experimental model; they do not establish a human cognitive response.

How do delivery and institutional quotations work?

Use the live checkout for the available price, stock, shipping methods and final charge. Institutions can request quotations or purchase-order references through Core Research’s procurement route; raise any specific lot or documentation condition before ordering.

What should we do if the item is damaged or labelled incorrectly?

Preserve the packaging and lot information, take clear photographs and contact Core Research with your order details before using the material in an experiment.

Research references

[1] Agapova TY et al. (2007). Semax and neurotrophin gene expression in rat brain regions. PMID 17353092. View research record

[2] Semax and Pro-Gly-Pro activate transcription of neurotrophin and receptor genes after rat cerebral ischaemia (2009). PMID 19633950. View research record

[3] Dergunova LV et al. (2021). Semax and pro-inflammatory mediator transcripts in rat ischaemia–reperfusion. PMID 34097675. View research record

Additional information

Format

Vial

Strength

10mg